Clinical, Protocol and Data Management

临床、方案和数据管理

基本信息

  • 批准号:
    10439832
  • 负责人:
  • 金额:
    $ 30.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

CPDM PROJECT SUMMARY The Clinical Protocol and Data Management component of the Dan L Duncan Comprehensive Cancer Center (DLDCCC) includes the Clinical Trials Support Unit (CTSU) and the Data Review and Safety Monitoring Committees. The CTSU provides central management, research support, and oversight functions for the conduct of cancer-related clinical trials at all ambulatory care centers and hospitals that are part of the DLDCCC. CTSU services are available to all members of the DLDCCC engaged in clinical research. The major functions of the CTSU are to provide: 1. Assistance with regulatory and administrative matters relating to clinical research and trials, including IRB compliance and approval, ongoing amendments and renewal, external agency compliance (such as the FDA), and maintenance of regulatory files, 2. Clinical trials informatics expertise, in particular maintaining an electronic database of cancer-related clinical protocols, patient registry and clinical data, and monitoring and reporting on accrual, 3. Quality Assurance/Quality Control auditing and personnel training to ensure that the research team is trained in best practices in clinical research, and 4. Research nursing/clinical trials management. In the most recent year 01/01/2018–12/31/2018, the CTSU supported 224 interventional trials including 54 investigator-initiated studies, 30 of which are conducted under IND and 3 under an IDE. The Data Review and Safety Monitoring Committees are separate from the operational aspect of clinical trials managed by the CTSU and function to ensure the safety of participants, the validity of data, and the appropriate termination of studies in the event that undue risks have been uncovered, or it appears that trials cannot be conducted successfully. The DLDCCC patient safety officer ensures that all data monitoring for Cancer Center trials is conducted in accordance with the approved monitoring plan. The CPDM also monitors accrual to ensure there is appropriate representation of women, minorities, children, and older adults in clinical research.
CPDM项目总结 丹·L邓肯综合肿瘤中心的临床方案和数据管理组件 (DLDCCC)包括临床试验支持股(CTSU)和数据审查和安全监测 委员会。CTSU为行为提供中央管理、研究支持和监督职能 参与DLDCCC的所有非卧床护理中心和医院的癌症相关临床试验。CTSU DLDCCC的所有从事临床研究的成员都可以获得服务。的主要职能 CTSU将提供: 1.协助与临床研究和试验有关的监管和行政事务,包括IRB 合规和批准、持续的修订和续订、外部机构合规(如 FDA),以及管理文件的维护, 2.临床试验信息学专门知识,特别是维持与癌症有关的临床电子数据库 协议、患者登记和临床数据,以及对应计项目的监测和报告, 3.质量保证/质量控制审核和人员培训,以确保研究团队得到培训 在临床研究的最佳实践中,以及 4.科研护理/临床试验管理。在最近一年1/01/2018-12/31/2018,CTSU 支持了224项干预试验,包括54项由调查员发起的研究,其中30项研究是在 IND和3在一个IDE下。 数据审查和安全监测委员会与临床试验的操作方面是分开的 由CTSU管理,其职能是确保参与者的安全、数据的有效性和适当的 在发现不适当风险的情况下终止研究,或试验似乎不能 进行得很成功。DLDCCC患者安全官员确保癌症中心的所有数据监测 根据批准的监测计划进行试验。 CPDM还监测应计收入,以确保妇女、少数群体、儿童、 以及临床研究中的老年人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha P. Mims其他文献

Paraneoplastic Nephrotic Syndrome and Inflammatory Arthritis at Diagnosis in Hodgkin Lymphoma
  • DOI:
    10.1016/j.clml.2012.09.006
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Daniel B. Aruch;Martha P. Mims
  • 通讯作者:
    Martha P. Mims
Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System
  • DOI:
    10.1182/blood-2023-173927
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jun Yang Jiang;Chijioke Nze;Danielle Guffey;Rockbum Kim;Abiodun O. Ouyomi;Omar Rosales;Raka Bandyo;Akiva Diamond;Gustavo A. Rivero;Courtney Nicole Miller-Chism;Mark M. Udden;Martha P. Mims;Christopher R. Flowers;Ang Li;Purnima Sravanti Teegavarapu
  • 通讯作者:
    Purnima Sravanti Teegavarapu
Disparities Among Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia
  • DOI:
    10.1182/blood-2023-190913
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Elyse Lopez;Deepa Dongarwar;Martha P. Mims;Sara Taveras Alam
  • 通讯作者:
    Sara Taveras Alam
Real-World Validation of the European Leukemia Network 2022 Risk Stratification in Acute Myelogenous Leukemia
  • DOI:
    10.1182/blood-2023-189309
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Sarah Elizabeth Mudra;Paul Sackstein;Lacey Scott Williams;Garrett Diltz;Rachel Zemel;Ashwin Kumar;Purnima Sravanti Teegavarapu;Martha P. Mims;Catherine Lai;Kimberley Doucette;Gustavo A. Rivero
  • 通讯作者:
    Gustavo A. Rivero
Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system
  • DOI:
    10.1016/j.bneo.2024.100020
  • 发表时间:
    2024-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jun Y. Jiang;Chijioke Nze;Danielle Guffey;Rockbum Kim;Abiodun O. Oluyomi;Omar Rosales;Raka Bandyo;Courtney N. Miller-Chism;Mark M. Udden;Martha P. Mims;Hilary Ma;Gustavo A. Rivero;Akiva Diamond;Purnima S. Teegavarapu;Ang Li;Christopher R. Flowers
  • 通讯作者:
    Christopher R. Flowers

Martha P. Mims的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha P. Mims', 18)}}的其他基金

CLINICAL TRIALS SUPPORT UNIT
临床试验支持单位
  • 批准号:
    8181015
  • 财政年份:
    2010
  • 资助金额:
    $ 30.26万
  • 项目类别:
Clinical, Protocol and Data Management
临床、方案和数据管理
  • 批准号:
    10674569
  • 财政年份:
    2007
  • 资助金额:
    $ 30.26万
  • 项目类别:
Clinical Trials Support Unit
临床试验支持单位
  • 批准号:
    7514693
  • 财政年份:
    2007
  • 资助金额:
    $ 30.26万
  • 项目类别:
DMT1:Tissue specific expression & alternative splicing
DMT1:组织特异性表达
  • 批准号:
    6858234
  • 财政年份:
    2005
  • 资助金额:
    $ 30.26万
  • 项目类别:
DMT1:Tissue specific expression & alternative splicing
DMT1:组织特异性表达
  • 批准号:
    7031607
  • 财政年份:
    2005
  • 资助金额:
    $ 30.26万
  • 项目类别:
DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORS
APOE 与脂蛋白和受体结合的动力学
  • 批准号:
    2223250
  • 财政年份:
    1993
  • 资助金额:
    $ 30.26万
  • 项目类别:
DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORS
APOE 与脂蛋白和受体结合的动力学
  • 批准号:
    2392677
  • 财政年份:
    1993
  • 资助金额:
    $ 30.26万
  • 项目类别:
DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORS
APOE 与脂蛋白和受体结合的动力学
  • 批准号:
    2223251
  • 财政年份:
    1993
  • 资助金额:
    $ 30.26万
  • 项目类别:
DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORS
APOE 与脂蛋白和受体结合的动力学
  • 批准号:
    2223252
  • 财政年份:
    1993
  • 资助金额:
    $ 30.26万
  • 项目类别:
DYNAMICS OF APOE BINDING TO LIPOPROTEINS AND RECEPTORS
APOE 与脂蛋白和受体结合的动力学
  • 批准号:
    3366035
  • 财政年份:
    1993
  • 资助金额:
    $ 30.26万
  • 项目类别:

相似海外基金

Integrating mental health screening into endocrinology ambulatory care
将心理健康筛查纳入内分泌门诊护理
  • 批准号:
    23K16283
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Improving Diagnostic Equity in Ambulatory care Settings (I.D.E.A.S.): Research to Practice
提高门诊护理环境中的诊断公平性 (I.D.E.A.S.):研究到实践
  • 批准号:
    10830121
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Patient-Centered Stewardship to Improve Antibiotic Use in Ambulatory Care
以患者为中心的管理,以改善门诊护理中抗生素的使用
  • 批准号:
    10801756
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Resilience to Covid-19 Disrupted Chronic Condition Care for Older Veterans At Risk of Hospitalization: Role of VA Ambulatory Care and VA Extended Care Home and Community-Based Care Supports
有住院风险的老年退伍军人对 Covid-19 中断的慢性病护理的恢复能力:VA 门诊护理和 VA 延伸护理之家和社区护理支持的作用
  • 批准号:
    10632920
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Patient-Reported Diagnostic Safety Events in Ambulatory Care Settings: A National Survey of Systemic Influences, Disparities and Persisting Consequences
门诊医疗机构中患者报告的诊断安全事件:系统性影响、差异和持续后果的全国调查
  • 批准号:
    10830011
  • 财政年份:
    2023
  • 资助金额:
    $ 30.26万
  • 项目类别:
Evaluating the Impact of Telemedicine on Ambulatory Care
评估远程医疗对门诊护理的影响
  • 批准号:
    10438959
  • 财政年份:
    2022
  • 资助金额:
    $ 30.26万
  • 项目类别:
Evaluating the Impact of Telemedicine on Ambulatory Care
评估远程医疗对门诊护理的影响
  • 批准号:
    10606533
  • 财政年份:
    2022
  • 资助金额:
    $ 30.26万
  • 项目类别:
Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
组件 A _ 德克萨斯州季节性流感、COVID-19 和其他呼吸道病毒疫苗针对急性疾病门诊护理的可信有效性措施(以及组件 D)。
  • 批准号:
    10618502
  • 财政年份:
    2022
  • 资助金额:
    $ 30.26万
  • 项目类别:
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
RFA-IP-22-004,组件 A _ 德克萨斯州季节性流感、COVID-19 和其他呼吸道病毒疫苗针对急性疾病门诊护理的可信有效性措施(和组件 D)。
  • 批准号:
    10698200
  • 财政年份:
    2022
  • 资助金额:
    $ 30.26万
  • 项目类别:
Acute Care Use by Patients with Inflammatory Arthritis Conditions: Health System Impact and Solutions for Ensuring Appropriate Ambulatory Care Access
炎症性关节炎患者的急性护理使用:卫生系统影响和确保获得适当门诊护理的解决方案
  • 批准号:
    456742
  • 财政年份:
    2021
  • 资助金额:
    $ 30.26万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了